DIREVO Strengthens Management Team

11-Nov-2011 - DIREVO Industrial Biotechnology GmbH announced that Klaudija Milos and Dr. Albrecht Laeufer joined the management team of the Company. With the addition of Klaudija and Albrecht, the restructuring of DIREVO’s management is completed to back the recently implemented product development and growth ...

Change in Leadership at DIREVO Industrial Biotechnology GmbH

05-May-2010 - DIREVO Industrial Biotechnology GmbH announced that effective May 1st Dr. Jorg Riesmeier was promoted to Chief Executive Officer. Dr. Riesmeier who joined on January 15, 2010 as Chief Operating Officer is succeeding Dr. Thomas von Rüden who advocated the change in leadership. Dr. von Rüden will ...

DIREVO Industrial Biotechnology GmbH appoints Dr. Joerg Riesmeier as COO

19-Jan-2010 - DIREVO Industrial Biotechnology GmbH (DIREVO) announced the appointment of Dr. Joerg Riesmeier as Managing Director and Chief Operating Officer with immediate effect. Dr. Riesmeier is an executive with a proven track record in industrial biotechnology, both in long-range industry investment and ...

DIREVO Industrial Biotechnology: Manfred Eigen Laboratory Inaugurated

10-Jul-2009 - DIREVO Industrial Biotechnology GmbH announced that it has completed the move to new premises of its own at the BioCampus Cologne. This is another important step in building up the company to figure as a major player in industrial biotechnology. It was further announced that DIREVO is dedicating ...

DIREVO Announces Incorporation of Industrial Biotechnology Subsidiary

29-Jul-2008 - DIREVO Biotech AG announced the incorporation of a fully owned subsidiary named DIREVO Industrial Biotechnology GmbH. The new company was formed to spin-out DIREVO's industrial biotechnology business unit established at the beginning of 2007 and the recently acquired AC Biotec GmbH. The new ...

DIREVO announces transfer of patents from Evotec

11-Jul-2008 - DIREVO Biotech AG announced that it has entered into an agreement with Evotec under which Evotec will transfer certain patents to DIREVO that are currently licensed by DIREVO. Such patents protect key components of DIREVO's unique and proven protein/strain engineering platform. Using this ...

Direvo and Danisco/Genencor sign second cooperation agreement

03-Jul-2008 - DIREVO Biotech AG and Genencor Division of Danisco A/S announced the signing of their second collaboration agreement. Under the terms of the agreement, Danisco will obtain worldwide exclusive rights to commercialize the product or products developed under this collaboration. In return, Direvo ...

DIREVO Receives Broad European Patent Protection for its Protease Optimization Platform

25-Jun-2008 - DIREVO Biotech AG announced receipt of notice from the European Patent Office that the post-granting opposition period had ended without a filed opposition against Patent Grant No. EP 150411. This patent, entitled, "Process for Generating Sequence-Specific Proteases by Directed Evolution", ...

DIREVO announces validation of bestMab

New approach for the optimization of therapeutic antibodies generates optiMIRA, an enhanced version of Adalimumab (Humira)

08-May-2008 - DIREVO Biotech AG announced that it has validated its "bestMab(TM)" platform through the generation of an optimized version of the anti-inflammatory antibody, Adalimumab (Humira®), with unprecedentedly strong binding properties. optiMIRA(TM) shows 300-times tighter antigen binding than Humira®, ...

DIREVO to collaborate with MedImmune on therapeutic protease for the treatment of CNS diseases

25-Jan-2008 - DIREVO Biotech AG announced the signing of a research and license agreement with MedImmune, the global biologics unit of AstraZeneca plc, to develop a therapeutic protease for the treatment of CNS diseases. Under the terms of the agreement, Direvo will be applying its proprietary ...